Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1967 1
1968 1
1969 1
1970 4
1971 1
1972 3
1973 1
1974 7
1975 7
1976 11
1977 10
1978 10
1979 6
1980 11
1981 11
1982 6
1983 8
1984 7
1985 19
1986 16
1987 19
1988 27
1989 21
1990 14
1991 22
1992 14
1993 38
1994 24
1995 28
1996 24
1997 24
1998 45
1999 36
2000 50
2001 53
2002 34
2003 38
2004 39
2005 46
2006 29
2007 28
2008 36
2009 43
2010 41
2011 40
2012 45
2013 37
2014 50
2015 37
2016 40
2017 52
2018 56
2019 63
2020 64
2021 39
Text availability
Article attribute
Article type
Publication date

Search Results

1,353 results
Results by year
Filters applied: . Clear all
Page 1
Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines 2015.
Yokoe M, Takada T, Mayumi T, Yoshida M, Isaji S, Wada K, Itoi T, Sata N, Gabata T, Igarashi H, Kataoka K, Hirota M, Kadoya M, Kitamura N, Kimura Y, Kiriyama S, Shirai K, Hattori T, Takeda K, Takeyama Y, Hirota M, Sekimoto M, Shikata S, Arata S, Hirata K. Yokoe M, et al. Among authors: kitamura n. J Hepatobiliary Pancreat Sci. 2015 Jun;22(6):405-32. doi: 10.1002/jhbp.259. Epub 2015 May 13. J Hepatobiliary Pancreat Sci. 2015. PMID: 25973947 Review.
Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.
Tazawa R, Ueda T, Abe M, Tatsumi K, Eda R, Kondoh S, Morimoto K, Tanaka T, Yamaguchi E, Takahashi A, Oda M, Ishii H, Izumi S, Sugiyama H, Nakagawa A, Tomii K, Suzuki M, Konno S, Ohkouchi S, Tode N, Handa T, Hirai T, Inoue Y, Arai T, Asakawa K, Sakagami T, Hashimoto A, Tanaka T, Takada T, Mikami A, Kitamura N, Nakata K. Tazawa R, et al. Among authors: kitamura n. N Engl J Med. 2019 Sep 5;381(10):923-932. doi: 10.1056/NEJMoa1816216. N Engl J Med. 2019. PMID: 31483963 Clinical Trial.
Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1.
Jin J, Togo S, Kadoya K, Tulafu M, Namba Y, Iwai M, Watanabe J, Nagahama K, Okabe T, Hidayat M, Kodama Y, Kitamura H, Ogura T, Kitamura N, Ikeo K, Sasaki S, Tominaga S, Takahashi K. Jin J, et al. Among authors: kitamura n. Respir Res. 2019 Jun 11;20(1):119. doi: 10.1186/s12931-019-1093-z. Respir Res. 2019. PMID: 31185973 Free PMC article.
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L.
Sacco MD, Ma C, Lagarias P, Gao A, Townsend JA, Meng X, Dube P, Zhang X, Hu Y, Kitamura N, Hurst B, Tarbet B, Marty MT, Kolocouris A, Xiang Y, Chen Y, Wang J. Sacco MD, et al. Among authors: kitamura n. Sci Adv. 2020 Dec 9;6(50):eabe0751. doi: 10.1126/sciadv.abe0751. Print 2020 Dec. Sci Adv. 2020. PMID: 33158912 Free PMC article.
Megalin-Mediated Tubuloglomerular Alterations in High-Fat Diet-Induced Kidney Disease.
Kuwahara S, Hosojima M, Kaneko R, Aoki H, Nakano D, Sasagawa T, Kabasawa H, Kaseda R, Yasukawa R, Ishikawa T, Suzuki A, Sato H, Kageyama S, Tanaka T, Kitamura N, Narita I, Komatsu M, Nishiyama A, Saito A. Kuwahara S, et al. Among authors: kitamura n. J Am Soc Nephrol. 2016 Jul;27(7):1996-2008. doi: 10.1681/ASN.2015020190. Epub 2015 Nov 3. J Am Soc Nephrol. 2016. PMID: 26534923 Free PMC article.
Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design.
Fujiki S, Iijima K, Okabe M, Niwano S, Tsujita K, Naito S, Ando K, Kusano K, Kato R, Nitta J, Miura T, Mitsuhashi T, Kario K, Kondo Y, Ieda M, Hagiwara N, Murohara T, Takahashi K, Tomita H, Takeishi Y, Anzai T, Shimizu W, Watanabe M, Morino Y, Kato T, Tada H, Nakagawa Y, Yano M, Maemura K, Kimura T, Yoshida H, Ota K, Tanaka T, Kitamura N, Node K, Aizawa Y, Shimizu I, Izumi D, Ozaki K, Minamino T; EMPA-ICD investigators. Fujiki S, et al. Among authors: kitamura n. Diabetes Ther. 2020 Nov;11(11):2739-2755. doi: 10.1007/s13300-020-00924-9. Epub 2020 Sep 23. Diabetes Ther. 2020. PMID: 32968947 Free PMC article.
Inhaled GM-CSF for Pulmonary Alveolar Proteinosis. Reply.
Tazawa R, Kitamura N, Nakata K. Tazawa R, et al. Among authors: kitamura n. N Engl J Med. 2020 Jan 9;382(2):198. doi: 10.1056/NEJMc1914606. N Engl J Med. 2020. PMID: 31914250 No abstract available.
1,353 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page